BIOGEN INC. Accounts Receivable 2008-2025 | BIIB
Beta
What is accounts receivable?
Accounts receivable represents money owed to the company by customers for goods or services already delivered but not yet paid for.
What is BIOGEN INC.'s current accounts receivable?
BIOGEN INC. (BIIB) annual accounts receivable for 2025 was $1.34B, a 4.44% decline from 2024. BIOGEN INC. accounts receivable for the quarter ending December 31, 2025 was $1.34B.
What was BIOGEN INC.'s accounts receivable in 2024?
BIOGEN INC. annual accounts receivable for 2024 was $1.40B, a 15.58% decline from 2023.
What was BIOGEN INC.'s accounts receivable in 2023?
BIOGEN INC. annual accounts receivable for 2023 was $1.66B, a 2.40% decline from 2022.
What is BIOGEN INC.'s 5-year accounts receivable CAGR?
BIOGEN INC. accounts receivable grew at a compound annual growth rate (CAGR) of 6.85% from FY2020 to FY2025, going from $1.91B to $1.34B over 5 years.
Accounts Receivable History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Declining
CAGR-6.8%
FY2020
$1.91B
→
FY2025
$1.34B
080910111213141516171819202122232425
5 years selected
Accounts Receivable History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $1.34B | -4.4% | 10-K |
| FY2024 | $1.40B | -15.6% | 10-K |
| FY2023 | $1.66B | -2.4% | 10-K |
| FY2022 | $1.71B | +10.0% | 10-K |
| FY2021 | $1.55B | -19.0% | 10-K |
| FY2020 | $1.91B | +1.8% | 10-K |
| FY2019 | $1.88B | -4.0% | 10-K |
| FY2018 | $1.96B | +9.6% | 10-K |
| FY2017 | $1.79B | +24.0% | 10-K |
| FY2016 | $1.44B | +17.5% | 10-K |
| FY2015 | $1.23B | -5.1% | 10-K |
| FY2014 | $1.29B | +56.8% | 10-K |
| FY2013 | $824.4M | +20.0% | 10-K |
| FY2012 | $686.8M | +17.5% | 10-K |
| FY2011 | $584.6M | -3.4% | 10-K |
| FY2010 | $605.3M | +9.8% | 10-K |
| FY2009 | $551.2M | +23.4% | 10-K |
| FY2008 | $446.7M | - | 10-K |
Company: BIOGEN INC.Ticker: BIIBSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →